Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles - Wikidata - awgldk - TriplyDB

Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles

Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles

http://www.wikidata.org/entity/Q28546068

about

GLUT1-mediated selective tumor targeting with fluorine containing platinum(II) glycoconjugates Methyl 6-Amino-6-deoxy-d-pyranoside-Conjugated Platinum(II) Complexes for Glucose Transporter (GLUT)-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism.Higher Expression of ERCC1 May Be Associated with Resistance to Adjuvant Platinum-Based Chemotherapy in Gastric Cancer.The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer.MRP2 and the Transport Kinetics of Cysteine Conjugates of Inorganic Mercury.Pharmacokinetics of Irinotecan, Oxaliplatin and 5-Fluorouracil During Hepatic Artery Chronomodulated Infusion: A Translational European OPTILIV Study.The Effects of Synthetically Modified Natural Compounds on ABC Transporters

P2860

Q33889236-2A48F7B9-03C7-451A-A870-1F789AEF85E5 Q38773938-4430A6A7-ED83-4496-9437-C335D8ABCC2D Q39012762-45D52A3D-A6C5-45C9-B652-8A4A862BEA59 Q39196784-03CFA30D-B86E-48D1-AD90-60E913CE976B Q41471256-9ADEFA56-A37F-409F-A83D-E44779E0C89D Q46294445-C3B31BAF-66DB-46B6-845F-3FB9FD23A2CC Q53064537-22DEDA02-3438-452C-BE1F-DAD743C202EA Q58791987-9FB70F07-6DCE-42F5-B584-D46F6DACF373

P2860

Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles

http://www.wikidata.org/entity/Q28546068

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Multidrug Resistance-Associate ...... Platinum in Membrane Vesicles

@ast

Multidrug Resistance-Associate ...... Platinum in Membrane Vesicles

@en

Multidrug Resistance-Associate ...... Platinum in Membrane Vesicles

@nl

type

label

Multidrug Resistance-Associate ...... Platinum in Membrane Vesicles

@ast

Multidrug Resistance-Associate ...... Platinum in Membrane Vesicles

@en

Multidrug Resistance-Associate ...... Platinum in Membrane Vesicles

@nl

prefLabel

Multidrug Resistance-Associate ...... Platinum in Membrane Vesicles

@ast

Multidrug Resistance-Associate ...... Platinum in Membrane Vesicles

@en

Multidrug Resistance-Associate ...... Platinum in Membrane Vesicles

@nl

P1433

Q28546068-34E1122C-732B-4527-B1CE-0998E83BC6A1

P1476

Q28546068-1C8E493C-B74A-4059-AB5B-00F2300B333B

P2093

Q28546068-0DC129B8-6816-480C-9158-A8A2F57A25A9

Q28546068-2EBDA337-A45D-4A17-965F-2AAE0691C65E

P2860

Q28546068-0F9133A0-A621-4D06-8404-27A7C106FFB2

Q28546068-14999571-4DDD-475F-9D22-F9A79A7FE580

Q28546068-232151F6-BE07-4018-BA23-85B75762ADFD

Q28546068-238B7505-4707-4B6E-AC0B-BCE5E9F419B3

Q28546068-2990C4DA-6891-4573-B15C-6990E6856040

Q28546068-2A940891-34CB-4191-9E69-9CCD54859157

Q28546068-2B3E609E-E765-495C-8C21-A526968E9AC5

Q28546068-318F585D-ED54-42FA-A187-D200E1628700

Q28546068-3B80B73B-4831-4CEC-B799-6BC570902C02

Q28546068-41467147-2B0B-447E-96D1-679E2E2D23C7

P304

Q28546068-532D378F-0D8D-48FA-A2A0-2E5AC2FEC309

P31

Q28546068-24E8C9FA-2B6F-455B-AA37-FB089D5099DF

P356

Q28546068-88D7566D-471B-4DA6-99BE-7F1DE6853CFC

P407

Q28546068-BE493CED-1782-4F50-B8DB-29CEF6C941EE

P433

Q28546068-A7E9A84F-4411-42CA-A2A0-D36761DFA467

P478

Q28546068-A3D531E7-0CAA-4B38-AE01-403BF409BFDB

P50

Q28546068-3F53D6EF-2544-4491-9227-B058F7CA5DA5

Q28546068-9B25B179-4C74-4793-98D5-C4F38795BC3C

P577

Q28546068-AA8E4682-8E7E-40AA-BC3C-437635AD7BB6

P5875

Q28546068-24295694-B1D0-4F32-86F2-731516610EBC

P698

Q28546068-D8798A67-91CA-4E11-ABC4-85E0C8EA15FB

P921

Q28546068-D49EF519-BE37-4D6D-9528-64AF211FA5D1

P932

Q28546068-9BDDFA8C-6630-4DE7-96F8-72BFF98F0235

P356

JOURNAL.PONE.0130727

P1433

P1476

Multidrug Resistance-Associate ...... Platinum in Membrane Vesicles

@en

P2093

Khine Myint

http://www.w3.org/2001/XMLSchema#string

Yan Li

http://www.w3.org/2001/XMLSchema#string

P2860

A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation

Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Cellular processing of platinum anticancer drugs

Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.

Role of organic cation transporter 1, OCT1 in the pharmacokinetics and toxicity of cis-diammine(pyridine)chloroplatinum(II) and oxaliplatin in mice.

Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs.

Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2

P304

e0130727

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0130727

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

James W. Paxton

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279732294

http://www.w3.org/2001/XMLSchema#string

P698

26131551

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

4488857

http://www.w3.org/2001/XMLSchema#string